Literature DB >> 7572801

Myoglobin in the early evaluation of acute chest pain.

C Montague1, T Kircher.   

Abstract

Two thirds of patients hospitalized to rule out acute myocardial infarction (AMI) are eventually found to have a non-AMI diagnosis, whereas 2% to 8% of patients with AMI are inappropriately discharged from the emergency department. Myoglobin has been shown to increase within 2 to 3 hours of myocardial injury. This study evaluates the usefulness of myoglobin in acute chest pain. Serial blood samples were obtained from 89 suspected AMI patients evaluated in the emergency department. Testing included creatine kinase (CK), a creatine kinase isoenzyme (CK-MB), and myoglobin. Twenty five of 89 patients (28%) had a diagnosis of AMI. The sensitivity of myoglobin for the detection of AMI was 56% at the time of admission and 100% 2 hours after admission. Thirteen of 25 AMI patients (52%) had a positive myoglobin before increases in CK or CK-MB, including one patient discharged from the emergency department. More importantly, the negative predictive value for myoglobin at the time of admission was 83% and was 100% two hours after admission. This potential for 100% predictability in excluding AMI by the use of serial myoglobin determinations will be very helpful in the correct triage of patients presenting with acute chest pain.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7572801     DOI: 10.1093/ajcp/104.4.472

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

Review 1.  Plasmonic technology: novel approach to ultrasensitive immunoassays.

Authors:  Joseph R Lakowicz; Joanna Malicka; Evgenia Matveeva; Ignacy Gryczynski; Zygmunt Gryczynski
Journal:  Clin Chem       Date:  2005-07-28       Impact factor: 8.327

2.  Microwave-accelerated metal-enhanced fluorescence (MAMEF): application to ultra fast and sensitive clinical assays.

Authors:  Kadir Aslan; Chris D Geddes
Journal:  J Fluoresc       Date:  2005-12-22       Impact factor: 2.217

Review 3.  Emergency department chest pain units and the role of radionuclide imaging.

Authors:  B G Abbott; F J Wackers
Journal:  J Nucl Cardiol       Date:  1998 Jan-Feb       Impact factor: 5.952

4.  Myoglobin immunoassay based on metal particle-enhanced fluorescence.

Authors:  Evgenia G Matveeva; Zygmunt Gryczynski; Joseph R Lakowicz
Journal:  J Immunol Methods       Date:  2005-07       Impact factor: 2.303

5.  A prospective study of an algorithm using cardiac troponin I and myoglobin as adjuncts in the diagnosis of acute myocardial infarction and intermediate coronary syndromes in a veteran's hospital.

Authors:  A S Maisel; K Templin; M Love; P Clopton
Journal:  Clin Cardiol       Date:  2000-12       Impact factor: 2.882

6.  Myoglobin immunoassay utilizing directional surface plasmon-coupled emission.

Authors:  Evgenia Matveeva; Zygmunt Gryczynski; Ignacy Gryczynski; Joanna Malicka; Joseph R Lakowicz
Journal:  Anal Chem       Date:  2004-11-01       Impact factor: 6.986

7.  Selective Recognition of Myoglobin in Biological Samples Using Molecularly Imprinted Polymer-Based Affinity Traps.

Authors:  Rüstem Keçili
Journal:  Int J Anal Chem       Date:  2018-08-08       Impact factor: 1.885

8.  IFCC Committee on Standardization of Markers of Cardiac Damage: Premises and Project Presentation.

Authors: 
Journal:  EJIFCC       Date:  1999-07-07

9.  Microwave-Accelerated and Metal-Enhanced Fluorescence Myoglobin Detection on Silvered Surfaces: Potential Application to Myocardial Infarction Diagnosis.

Authors:  Kadir Aslan; Chris D Geddes
Journal:  Plasmonics       Date:  2006-03-01       Impact factor: 2.404

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.